Needle fear: A point prevalence survey of dialysis patients

Shanahan, Lisa; Leu, R.; Whittington, Tiffany; Biddle, Amanda; McDonald, S.; Bennett, Paul N.; Jesudason, Shilpanjali

doi:10.1111/hdi.12752

Cited by 7 publications

(10 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Articles included 24 cross-sectional studies [ 1 – 3 , 25 , 26 , 28 – 30 , 33 , 36 , 37 , 39 – 45 , 47 , 50 – 52 ], one abstract of a literature review [ 38 ], one prospective cohort study [ 34 ], two case reports [ 31 , 48 ], one randomized controlled trial [ 24 ], and three reports [ 27 , 32 , 49 ]. The included studies used a variety of methodology to define and assess needle fear or phobia, ranging from a single question within a broader questionnaire, face-to face interviews to assessment of fear or phobia using a dedicated validated tool (eg.…”

Section: Resultsmentioning

confidence: 99%

“…Twenty-four articles assessed prevalence of needle fear [ 1 – 3 , 24 – 26 , 28 – 30 , 33 – 36 , 38 – 45 , 47 , 50 – 53 ], five described only management strategies or recommendations [ 27 , 31 , 32 , 48 , 49 ] and three reported both prevalence and management [ 2 , 24 , 34 ]. Of the eight articles that suggested management recommendations, three were underpinned by research evidence [ 27 ] or outcome data from quasi-experimental study [ 34 ] and randomised-controlled trial [ 24 ].…”

Section: Resultsmentioning

confidence: 99%

“…Needle fear was reported by 25–47% of adults receiving peritoneal dialysis or haemodialysis ( Table 2 , section 1b) [ 1 , 28 – 30 ]. Mulder et al’s [ 29 ] validation study of the Dialysis Fear of Injection Questionnaire (DFIQ) in haemodialysis patients revealed 20/45 (44%) had fear of needles in the pilot study.…”

Section: Resultsmentioning

confidence: 99%

“…In response to two researcher-administered questions, 198/551 (36%) of peritoneal and haemodialysis patients reported experiencing needle fear, 73/208 (37%) of whom indicated this had influenced their choice of kidney replacement therapy [ 30 ]. 13/53 (25%) of people who refused haemodialysis cited fear of needles and complications as a reason [ 1 ].…”

Section: Resultsmentioning

confidence: 99%

“…The D-FISQ and its variant, the DFIQ, were used among patients with diabetes or kidney failure, as a validated measure of fear of injection and or self-testing associated with insulin or dialysis therapies [ 29 , 34 , 36 , 42 , 45 , 46 , 53 ]. However, a variety of other assessment methods were used including psychometric self-report tools [ 25 , 26 , 35 , 39 ], investigator-created surveys [ 1 , 28 , 30 , 41 , 50 , 52 ], and face-to-face interviews [ 2 , 33 , 40 ]. Moreover, needle phobia was determined by single or multiple items on self-report measures [ 2 , 24 , 28 , 51 ], not formal diagnostic assessment.…”

Section: Discussionmentioning

confidence: 99%

See 4 more Smart Citations

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background Little is known about the prevalence and best management of needle fear in adults with chronic disease, who may experience frequent and long-term exposure to needles for lifesaving therapies such as renal dialysis and cancer treatment. Identifying interventions that assist in management of needle fear and associated distress is essential to support these patients with repeated needle and cannula exposure. Method We followed the PRISMA methodology for scoping reviews and systematically searched PsychINFO, PubMed (MEDLINE), ProQuest, Embase and grey literature and reference lists between 1989 and October 2020 for articles related to needle discomfort, distress, anxiety, fear or phobia. The following chronic diseases were included: arthritis, asthma, chronic back pain, cancer, cardiovascular disease, chronic obstructive pulmonary disease, diabetes, and mental illness, or kidney failure. Literature concerning dentistry, vaccination, intravenous drug users and paediatric populations were excluded. Results We identified 32 papers reporting prevalence (n = 24), management (n = 5) or both (n = 3). Needle fear prevalence varied in disease cohorts: 17–52% (cancer), 25–47% (chronic kidney disease) and 0.2–80% (diabetes). Assessment methods varied across studies. Management strategies had poor evidence-base, but included needle-specific education, decorated devices, cognitive-behavioural stress management techniques, distraction, and changing the therapy environment or modality. Conclusion Although needle fear is common there is a paucity of evidence regarding interventions to address it among adults living with chronic disease. This scoping review has highlighted the need for improved identification of needle fear in adults and development of interventions are required for these cohorts.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

Dialysis Needle-Related Distress: Patient Perspectives on Identification, Prevention, and Management

Duncanson,

Chur-Hansen,

Le Leu

et al. 2023

Kidney International Reports

View full text Add to dashboard Cite

The use of haemodialysis plastic cannula in prevalent patients with kidney failure: A feasibility crossover randomised trial study

Schoch

Bennett

2022

Journal of Renal Care

Self Cite

View full text Add to dashboard Cite

Background: Haemodialysis plastic cannulae have been limited to incident arteriovenous fistulae cannulation or in those who require a more flexible in situ access device. The feasibility of plastic cannulae in prevalent patients on haemodialysis has not been reported. Objective: To determine the feasibility of plastic cannulae in prevalent haemodialysis patients. Design: Prospective feasibility crossover randomised control trial. Participants: Adults diagnosed with chronic kidney disease G5 requiring haemodialysis three or more times per week via a native arteriovenous fistula previously cannulated for at least 6 weeks. Measurements: Cannulation success rate, cannulation manipulation type, arterial and venous needle pressure. Patient needle-related anxiety as measured by the 4-item Patient Health Questionnaire and Meditation in Dialysis Questionnaire and nurse satisfaction.Results: Eight patients completed 12 weeks plastic canulae and metal needles.Plastic cannulae were less likely to be successful in cannulation compared to metal needles (odds ratio = 0.15; 95% confidence interval [CI]: 0.05-0.48; p = 0.001). There was no effect of type of needle on the change in arterial needle pressure or change in venous needle pressure and no effect of plastic needle on repositioning (relative risk [RR] = 1.09; 95% CI: 0.385, 3.089; p = .871) or gauze pillow application (RR = 0.936; 95% CI: 0.467, 1.874; p = .851) than metal needles, relative to no manipulation. There were low rates of psychological distress or needle-related anxiety towards plastic or metal needles.Conclusions: Plastic cannulae are feasible in prevalent haemodialysis patients, however, metal needles are still preferred in a haemodialysis center that has historically used metal needles.

show abstract

Needle fear: A point prevalence survey of dialysis patients

Cited by 7 publications

References 5 publications

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review

Dialysis Needle-Related Distress: Patient Perspectives on Identification, Prevention, and Management

The use of haemodialysis plastic cannula in prevalent patients with kidney failure: A feasibility crossover randomised trial study

Contact Info

Product

Resources

About